EPCAM and colorectal carcinoma: It can be concluded that the arming of MSNs with EpCAM aptamer can improve drug delivery performance leading to markedly greater cytotoxicity, cellular uptake and increased apoptotic level in the CRC cells overexpressing EpCAM biomarker.